BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006;9:245-53. [DOI: 10.1007/s10120-006-0397-0] [Cited by in Crossref: 161] [Cited by in F6Publishing: 159] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Song D, Yue L, Li H, Zhang J, Yan Z, Fan Y, Yang H, Liu Q, Zhang D, Xia Z, Qin P, Jia J, Yue M, Yu J, Zheng S, Yang F, Wang J. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry. Br J Cancer 2016;114:929-38. [PMID: 27002935 DOI: 10.1038/bjc.2016.52] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Yang TW, Wang CC, Hung WC, Liu YH, Sung WW, Tsai MC. Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures. Front Public Health 2021;9:713895. [PMID: 34485236 DOI: 10.3389/fpubh.2021.713895] [Reference Citation Analysis]
3 Zhang L, Ren J, Pan K, Ma J, Li J, Shen L, Zhang X, Li J, Fan D, Gail M. Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening. Int J Cancer. 2010;126:469-473. [PMID: 19588495 DOI: 10.1002/ijc.24739] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cho EJ, Kim HK, Jeong TD, Ko DH, Bae SE, Lee JS, Lee W, Choe JW, Chun S, Jung HY, Min WK. Method evaluation of pepsinogen I/II assay based on chemiluminescent immunoassays and comparison with other test methods. Clin Chim Acta 2016;452:149-54. [PMID: 26585753 DOI: 10.1016/j.cca.2015.11.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Israeli I, Steiner J, Segev G, Kass PH, Suchodolski JS, Sattasathuchana P, Bruchim Y, Yudelevitch S, Aroch I. Serum pepsinogen-A, canine pancreatic lipase immunoreactivity, and C-reactive protein as prognostic markers in dogs with gastric dilatation-volvulus. J Vet Intern Med 2012;26:920-8. [PMID: 22594637 DOI: 10.1111/j.1939-1676.2012.00940.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
6 Leung WK, Wu M, Kakugawa Y, Kim JJ, Yeoh K, Goh KL, Wu K, Wu D, Sollano J, Kachintorn U, Gotoda T, Lin J, You W, Ng EK, Sung JJ. Screening for gastric cancer in Asia: current evidence and practice. The Lancet Oncology 2008;9:279-87. [DOI: 10.1016/s1470-2045(08)70072-x] [Cited by in Crossref: 533] [Cited by in F6Publishing: 289] [Article Influence: 38.1] [Reference Citation Analysis]
7 Kabir S. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Helicobacter. 2009;14:159-171. [PMID: 19702845 DOI: 10.1111/j.1523-5378.2009.00677.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
8 Lin JT. Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2014;12:135-138. [PMID: 24107396 DOI: 10.1016/j.cgh.2013.09.064] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
9 Wilunda C, Yamaji T, Iwasaki M, Inoue M, Tsugane S, Sawada N. Meat consumption and gastric cancer risk: The Japan Public Health Center-based Prospective Study. Am J Clin Nutr 2021:nqab367. [PMID: 34788357 DOI: 10.1093/ajcn/nqab367] [Reference Citation Analysis]
10 Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol. 2010;105:493-498. [PMID: 20203636 DOI: 10.1038/ajg.2009.728] [Cited by in Crossref: 191] [Cited by in F6Publishing: 183] [Article Influence: 15.9] [Reference Citation Analysis]
11 Barchi A, Miraglia C, Violi A, Cambiè G, Nouvenne A, Capasso M, Leandro G, Meschi T, De' Angelis GL, Di Mario F. A non-invasive method for the diagnosis of upper GI diseases. Acta Biomed 2018;89:40-3. [PMID: 30561417 DOI: 10.23750/abm.v89i8-S.7917] [Reference Citation Analysis]
12 Uno K, Iijima K, Hatta W, Koike T, Abe Y, Asano N, Kusaka G, Shimosegawa T. Direct measurement of gastroesophageal reflux episodes in patients with squamous cell carcinoma by 24-h pH-impedance monitoring. Am J Gastroenterol 2011;106:1923-9. [PMID: 21931379 DOI: 10.1038/ajg.2011.282] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
13 Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2-9. [PMID: 22188910 DOI: 10.1111/j.1751-2980.2011.00550.x] [Cited by in Crossref: 256] [Cited by in F6Publishing: 255] [Article Influence: 25.6] [Reference Citation Analysis]
14 Shiota S, Yamaoka Y. Biomarkers for Helicobacter pylori infection and gastroduodenal diseases. Biomark Med 2014;8:1127-37. [PMID: 25402582 DOI: 10.2217/bmm.14.72] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver. 2010;4:307-319. [PMID: 20981206 DOI: 10.5009/gnl.2010.4.3.307] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
16 Yamamichi N, Hirano C, Shimamoto T, Minatsuki C, Takahashi Y, Nakayama C, Matsuda R, Fujishiro M, Konno-Shimizu M, Kato J. Associated factors of atrophic gastritis diagnosed by double-contrast upper gastrointestinal barium X-ray radiography: a cross-sectional study analyzing 6,901 healthy subjects in Japan. PLoS One. 2014;9:e111359. [PMID: 25343257 DOI: 10.1371/journal.pone.0111359] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
17 Naito Y, Uchiyama K, Kinoshita Y, Fukudo S, Joh T, Suzuki H, Takahashi S, Ueno F, Fujiwara Y, Arakawa T, Matsumoto T, Hahm KB, Kachintorn U, Syam AF, Rani AA, Sollano JD, Zhu Q. A questionnaire-based survey on screening for gastric and colorectal cancer by physicians in East Asian countries in 2010. Digestion 2012;86:94-106. [PMID: 22846219 DOI: 10.1159/000339342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Xiang W, Wang R, Bai D, Yu T, Chen X; on behalf of the SIGES Research Groups. Helicobacter Pylori Related Gastric Cancer Screening and Cost-Effectiveness Analysis: A Hospital-Based Cross-Sectional Study (SIGES). Nutrition and Cancer. [DOI: 10.1080/01635581.2021.2022168] [Reference Citation Analysis]
19 Fan J, Xiao H, Zhang J, Zhou B, Deng L, Zhang Y, Huang B. A magnetic nanoparticle-labeled immunoassay with europium and samarium for simultaneous quantification of serum pepsinogen I and II. Br J Biomed Sci 2017;74:127-32. [PMID: 28521643 DOI: 10.1080/09674845.2017.1297216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Bostick RM, Wu X, Yuan Y. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study. Am J Gastroenterol. 2017;112:704-715. [PMID: 28323271 DOI: 10.1038/ajg.2017.55] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
21 Ikeda F, Shikata K, Hata J, Fukuhara M, Hirakawa Y, Ohara T, Mukai N, Nagata M, Yoshida D, Yonemoto K. Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study. J Epidemiol. 2016;26:629-636. [PMID: 27265836 DOI: 10.2188/jea.je20150258] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
22 Tsai KF, Liou JM, Chen MJ, Chen CC, Kuo SH, Lai IR, Yeh KH, Lin MT, Wang HP, Cheng AL, Lin JT, Shun CT, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer. PLoS One. 2017;12:e0170942. [PMID: 28152027 DOI: 10.1371/journal.pone.0170942] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
23 Loong TH, Soon NC, Nik Mahmud NRK, Naidu J, Rani RA, Abdul Hamid N, Elias MH, Mohamed Rose I, Tamil A, Mokhtar NM, Raja Ali RA. Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus. Biomed Rep 2017;7:460-8. [PMID: 29181158 DOI: 10.3892/br.2017.985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
24 Iijima K, Koike T, Abe Y, Yamagishi H, Ara N, Asanuma K, Uno K, Imatani A, Nakaya N, Ohara S. Gastric hyposecretion in esophageal squamous-cell carcinomas. Dig Dis Sci. 2010;55:1349-1355. [PMID: 19513836 DOI: 10.1007/s10620-009-0853-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
25 Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2-9. [PMID: 22188910 DOI: 10.1111/j.1751-2980.2011.00550] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Rugge M. Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication. Gastroenterology Clinics of North America 2015;44:609-24. [DOI: 10.1016/j.gtc.2015.05.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
27 Choi HS, Lee SY, Kim JH, Sung IK, Park HS, Shim CS, Jin CJ. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm. J Dig Dis. 2014;15:293-298. [PMID: 24602176 DOI: 10.1111/1751-2980.12144] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
28 Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low Prevalence of Helicobacter pylori-negative Gastric Cancer among Japanese: H. pylori-negative Gastric Cancer. Helicobacter 2011;16:415-9. [DOI: 10.1111/j.1523-5378.2011.00889.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 108] [Article Influence: 12.1] [Reference Citation Analysis]
29 Tänzer M, Liebl M, Quante M. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacol Ther. 2013;140:133-147. [PMID: 23791941 DOI: 10.1016/j.pharmthera.2013.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
30 Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P;  faculty members of Kyoto Global Consensus Conference. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353-1367. [PMID: 26187502 DOI: 10.1136/gutjnl-2015-309252] [Cited by in Crossref: 609] [Cited by in F6Publishing: 507] [Article Influence: 87.0] [Reference Citation Analysis]
31 Kwon Y, Jeon S, Nam S, Shin I. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection. Aliment Pharmacol Ther. 2017;46:758-767. [PMID: 28799258 DOI: 10.1111/apt.14263] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
32 Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J; Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008;23:351-365. [PMID: 18318820 DOI: 10.1111/j.1440-1746.2008.05314.x] [Cited by in Crossref: 218] [Cited by in F6Publishing: 203] [Article Influence: 15.6] [Reference Citation Analysis]
33 Kim HY, Kim N, Kang JM, Park YS, Lee DH, Kim YR, Kim JS, Jung HC, Song IS. Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea: . European Journal of Gastroenterology & Hepatology 2009;21:606-12. [DOI: 10.1097/meg.0b013e3283086757] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
34 Deng K, Lin S, Zhou L, Li Y, Chen M, Wang Y, Li Y. High levels of aromatic amino acids in gastric juice during the early stages of gastric cancer progression. PLoS One. 2012;7:e49434. [PMID: 23152906 DOI: 10.1371/journal.pone.0049434] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
35 Tokunaga M, Hiki N, Fukunaga T, Nunobe S, Ohyama S, Yamaguchi T. Laparoscopy-assisted Gastrectomy for Patients With Earlier Upper Abdominal Open Surgery. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2010;20:16-9. [DOI: 10.1097/sle.0b013e3181cdebdd] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
36 Myint T, Shiota S, Vilaichone RK, Ni N, Aye TT, Matsuda M, Tran TTH, Uchida T, Mahachai V, Yamaoka Y. Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar. World J Gastroenterol 2015; 21(2): 629-636 [PMID: 25605987 DOI: 10.3748/wjg.v21.i2.629] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
37 Terasawa T, Nishida H, Kato K, Miyashiro I, Yoshikawa T, Takaku R, Hamashima C. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis. PLoS One. 2014;9:e109783. [PMID: 25314140 DOI: 10.1371/journal.pone.0109783] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
38 Baek SM, Kim N, Kwon YJ, Lee HS, Kim HY, Lee J, Yoon H, Shin CM, Park YS, Lee DH. Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea. Gut Liver 2020;14:439-49. [PMID: 31533397 DOI: 10.5009/gnl19091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
39 Miraglia C, Moccia F, Russo M, Scida S, Franceschi M, Crafa P, Franzoni L, Nouvenne A, Meschi T, Leandro G, De' Angelis GL, Di Mario F. Non-invasive method for the assessment of gastric acid secretion. Acta Biomed 2018;89:53-7. [PMID: 30561418 DOI: 10.23750/abm.v89i8-S.7986] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Shimoyama T, Chinda D, Matsuzaka M, Takahashi I, Nakaji S, Fukuda S. Decrease of serum level of gastrin in healthy Japanese adults by the change of Helicobacter pylori infection: Gastrin level of healthy Japanese adults. J Gastroenterol Hepatol 2014;29:25-8. [DOI: 10.1111/jgh.12773] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
41 Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29:895-905. [PMID: 26651251 DOI: 10.1016/j.bpg.2015.09.013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 100] [Article Influence: 14.7] [Reference Citation Analysis]
42 Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Sci Rep. 2019;9:6099. [PMID: 30988344 DOI: 10.1038/s41598-019-42365-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
43 Li J, Lei J, He L, Fan X, Yi F, Zhang W. Evaluation and Monitoring of Superoxide Dismutase (SOD) Activity and its Clinical Significance in Gastric Cancer: A Systematic Review and Meta-Analysis. Med Sci Monit 2019;25:2032-42. [PMID: 30886134 DOI: 10.12659/MSM.913375] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
44 Selgrad M, Bornschein J, Rokkas T, Malfertheiner P. Helicobacter pylori: gastric cancer and extragastric intestinal malignancies. Helicobacter. 2012;17 Suppl 1:30-35. [PMID: 22958153 DOI: 10.1111/j.1523-5378.2012.00980.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
45 Frýdlová J, Tichá M, Kučerová Z. Optimization of Affinity Chromatography of Pepsins on Iodinated l-Tyrosine–Sepharose. Chroma 2008;67:41-5. [DOI: 10.1365/s10337-007-0464-7] [Reference Citation Analysis]
46 Kiso M, Yoshihara M, Ito M, Inoue K, Kato K, Nakajima S, Mabe K, Kobayashi M, Uemura N, Yada T. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study. Gastric Cancer. 2017;20:764-771. [PMID: 28025702 DOI: 10.1007/s10120-016-0682-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
47 Wu JY, Cheng CC, Wang JY, Wu DC, Hsieh JS, Lee SC, Wang WM. Discovery of tumor markers for gastric cancer by proteomics. PLoS One 2014;9:e84158. [PMID: 24404153 DOI: 10.1371/journal.pone.0084158] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
48 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011;396:729-742. [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
49 Miki K, Fujishiro M, Kodashima S, Yahagi N. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc. 2009;21:78-81. [PMID: 19691778 DOI: 10.1111/j.1443-1661.2009.00839.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
50 Correa P. Serum pepsinogens in gastric cancer screening. Dig Dis Sci. 2010;55:2123-2125. [PMID: 20428942 DOI: 10.1007/s10620-010-1248-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
51 Jiang W, Sun G, Zhang Y, Hu Z, Wen X, Men S, Xing Z, Zhang S, Huang B, Wang C. Simultaneous determination of gastric cancer biomarkers pepsinogen PGI/PGII using element tagged immunoassay coupled with inductively coupled plasma mass spectrometry detection. J Clin Lab Anal 2020;34:e23287. [PMID: 32147885 DOI: 10.1002/jcla.23287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
52 Lombardo L, Leto R, Molinaro G, Migliardi M, Ravarino N, Rocca R, Torchio B. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med. 2010;48:1327-1332. [PMID: 20604730 DOI: 10.1515/cclm.2010.256] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
53 Xu Y, Miremadi A, Link A, Malfertheiner P, Fitzgerald RC, Bornschein J. Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study. J Clin Pathol 2019;72:825-9. [PMID: 31235543 DOI: 10.1136/jclinpath-2019-205700] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Bel'skaya LV, Sarf EA, Shalygin SP, Postnova TV, Kosenok VK. Identification of salivary volatile organic compounds as potential markers of stomach and colorectal cancer: A pilot study. J Oral Biosci 2020;62:212-21. [PMID: 32474113 DOI: 10.1016/j.job.2020.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Yao Y, Ding Y, Bai Y, Zhou Q, Lee H, Li X, Teng L. Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer. Front Genet 2020;11:591515. [PMID: 33597967 DOI: 10.3389/fgene.2020.591515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Shimoyama T, Aoki M, Sasaki Y, Matsuzaka M, Nakaji S, Fukuda S. ABC screening for gastric cancer is not applicable in a Japanese population with high prevalence of atrophic gastritis. Gastric Cancer. 2012;15:331-334. [PMID: 22282137 DOI: 10.1007/s10120-012-0141-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
57 Weledji EP, Enow Orock G, Ngowe MN. Intestinal metaplasia and anastomotic recurrence of gastric carcinoma. J Gastrointest Oncol 2014;5:474-80. [PMID: 25436128 DOI: 10.3978/j.issn.2078-6891.2014.048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Bang CS, Lee JJ, Baik GH. Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. J Clin Med 2019;8:E657. [PMID: 31083485 DOI: 10.3390/jcm8050657] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
59 Ono S, Kato M, Suzuki M, Ishigaki S, Takahashi M, Haneda M, Mabe K, Shimizu Y. Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion. 2012;86:59-65. [PMID: 22722747 DOI: 10.1159/000339176] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
60 Cheng CW, Chang CC, Patria YN, Chang RT, Liu YR, Li FA, Shih HM, Lin CY. Sex hormone-binding globulin (SHBG) is a potential early diagnostic biomarker for gastric cancer. Cancer Med 2018;7:64-74. [PMID: 29148252 DOI: 10.1002/cam4.1254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
61 Song HJ, Jang SJ, Yun SC, Park YS, Kim MJ, Lee SM, Choi KD, Lee GH, Jung HY, Kim JH. Low Levels of Pepsinogen I and Pepsinogen I/II Ratio are Valuable Serologic Markers for Predicting Extensive Gastric Corpus Atrophy in Patients Undergoing Endoscopic Mucosectomy. Gut Liver 2010;4:475-80. [PMID: 21253295 DOI: 10.5009/gnl.2010.4.4.475] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
62 Cha JH, Jang JS. Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm. Korean J Intern Med 2020;35:550-8. [PMID: 30400679 DOI: 10.3904/kjim.2018.282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
63 Rajčanová M, Tichá M, Kučerová Z. Application of heptapeptides containing D-amino acid residues immobilized to magnetic particles and Sepharose for the study of binding properties of gastric aspartic proteases: Liquid Chromatography. J Sep Science 2012;35:1899-905. [DOI: 10.1002/jssc.201200221] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
64 González CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer. 2012;130:745-753. [PMID: 21918974 DOI: 10.1002/ijc.26430] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 8.8] [Reference Citation Analysis]
65 Walker EV, Girgis S, Yuan Y, Goodman KJ. Community-driven research in the canadian arctic: dietary exposure to methylmercury and gastric health outcomes. Int J Circumpolar Health 2021;80:1889879. [PMID: 33646085 DOI: 10.1080/22423982.2021.1889879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Haga K, Matsumoto K, Kitazawa T, Seto K, Fujita S, Hasegawa T. Cost of illness of the stomach cancer in Japan - a time trend and future projections. BMC Health Serv Res. 2013;13:283. [PMID: 23879739 DOI: 10.1186/1472-6963-13-283] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
67 Sun LP, Gong YH, Wang L, Yuan Y. Serum pepsinogen levels and their influencing factors: A population-based study in 6990 Chinese from North China. World J Gastroenterol 2007; 13(48): 6562-6567 [PMID: 18161928 DOI: 10.3748/wjg.v13.i48.6562] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
68 Shimoyama T, Chinda D, Sawada Y, Komai K, Chiba H, Saito Y, Sasaki Y, Matsuzaka M, Fukuda S. Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens. Intern Med 2017;56:1621-7. [PMID: 28674348 DOI: 10.2169/internalmedicine.56.7823] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
69 Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2-9. [PMID: 15306578 DOI: 10.1136/gut.2003.034629] [Cited by in Crossref: 252] [Cited by in F6Publishing: 241] [Article Influence: 25.2] [Reference Citation Analysis]
70 Zhou B, Zhou Z, Chen Y, Deng H, Cai Y, Rao X, Yin Y, Rong L. Plasma proteomics-based identification of novel biomarkers in early gastric cancer. Clinical Biochemistry 2020;76:5-10. [DOI: 10.1016/j.clinbiochem.2019.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
71 Miki K, Fujishiro M. Cautious comparison between East and West is necessary in terms of the serum pepsinogen test. Dig Endosc 2009;21:134-5. [PMID: 19691790 DOI: 10.1111/j.1443-1661.2009.00845.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
72 Tiwari AK, Laird-Fick HS, Wali RK, Roy HK. Surveillance for gastrointestinal malignancies. World J Gastroenterol 2012; 18(33): 4507-4516 [PMID: 22969223 DOI: 10.3748/wjg.v18.i33.4507] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
73 Na HK, Cho CJ, Bae SE, Lee JH, Park YS, Ahn JY, Kim DH, Choi KD, Song HJ, Lee GH, Jang SJ, Jung HY. Atrophic and Metaplastic Progression in the Background Mucosa of Patients with Gastric Adenoma. PLoS One 2017;12:e0169456. [PMID: 28072871 DOI: 10.1371/journal.pone.0169456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
74 Kang JM, Kim N, Yoo JY, Park YS, Lee DH, Kim HY, Lee HS, Choe G, Kim JS, Jung HC, Song IS. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter. 2008;13:146-156. [PMID: 18321304 DOI: 10.1111/j.1523-5378.2008.00592.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
75 Li K, Li X, Fan Y, Yang C, Lv X. Simultaneous detection of gastric cancer screening biomarkers plasma pepsinogen I/II using fluorescent immunochromatographic strip coupled with a miniature analytical device. Sensors and Actuators B: Chemical 2019;286:272-81. [DOI: 10.1016/j.snb.2019.01.149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
76 He CY, Sun LP, Gong YH, Xu Q, Dong NN, Yuan Y. Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs. J Gastroenterol Hepatol. 2011;26:1039-1046. [PMID: 21303408 DOI: 10.1111/j.1440-1746.2011.06692.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
77 Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, Vieira AS, Bento MJ, Lomba-Viana H. Serum pepsinogen test for early detection of gastric cancer in a European country. Eur J Gastroenterol Hepatol. 2012;24:37-41. [PMID: 21989121 DOI: 10.1097/meg.0b013e32834d0a0a] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
78 Kim HJ, Hwang SW, Kim N, Yoon H, Shin CM, Park YS, Lee DH, Park DJ, Kim HH, Kim JS, Jung HC, Lee HS. Helicobacter pylori and Molecular Markers as Prognostic Indicators for Gastric Cancer in Korea. J Cancer Prev 2014;19:56-67. [PMID: 25337573 DOI: 10.15430/jcp.2014.19.1.56] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
79 Chinda D, Shimoyama T, Mikami T, Arai T, Chiba D, Sasaki Y, Komai K, Sawada Y, Saito Y, Chiba H, Fukuda S; RINGO Study Group. Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among Group A subjects of ABC classification: a multicenter study. J Gastroenterol 2018;53:924-31. [DOI: 10.1007/s00535-018-1431-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
80 Ubukata H, Konishi S, Nakachi T, Motohashi G, Goto Y, Watanabe Y, Nakada I, Tabuchi T. Characteristics of the Serum Pepsinogen (PG) Test, and the Relationship between PG Test Results and Gastric Cancer Outcomes. Scand J Surg 2010;99:201-7. [DOI: 10.1177/145749691009900404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
81 Sjödahl K, Lagergren J. Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible? EPMA J 2010;1:461-71. [PMID: 23199088 DOI: 10.1007/s13167-010-0043-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
82 Shiotani A, Haruma K, Graham DY. Metachronous gastric cancer after successful Helicobacter pylori eradication. World J Gastroenterol 2014; 20(33): 11552-11559 [PMID: 25206262 DOI: 10.3748/wjg.v20.i33.11552] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
83 Heemskerk VH, Lentze F, Hulsewé KW, Hoofwijk TG. Gastric carcinoma: review of the results of treatment in a community teaching hospital. World J Surg Oncol 2007;5:81. [PMID: 17659085 DOI: 10.1186/1477-7819-5-81] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
84 Coelho LGV, Marinho JR, Genta R, Ribeiro LT, Passos MDCF, Zaterka S, Assumpção PP, Barbosa AJA, Barbuti R, Braga LL, Breyer H, Carvalhaes A, Chinzon D, Cury M, Domingues G, Jorge JL, Maguilnik I, Marinho FP, Moraes-filho JPD, Parente JML, Paula-e-silva CMD, Pedrazzoli-júnior J, Ramos AFP, Seidler H, Spinelli JN, Zir JV. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arq Gastroenterol 2018;55:97-121. [DOI: 10.1590/s0004-2803.201800000-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
85 Matsumoto H, Tsuchiya T, Yoshiura K, Hayashi T, Hidaka S, Nanashima A, Nagayasu T. ABCC11/MRP8 Expression in the Gastrointestinal Tract and a Novel Role for Pepsinogen Secretion. Acta Histochem Cytochem 2014;47:85-94. [PMID: 25320405 DOI: 10.1267/ahc.13040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
86 Chinda D, Shimoyama T, Iino C, Matsuzaka M, Nakaji S, Fukuda S. Decrease of Estradiol and Several Lifestyle Factors, but Not <b><i>Helicobacter pylori</i></b> Infection, Are Significant Risks for Osteopenia in Japanese Females. Digestion 2017;96:103-9. [DOI: 10.1159/000479317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
87 Ito M, Yoshihara M, Takata S, Wada Y, Matsuo T, Boda T, Tanaka S, Chayama K. Serum screening for detection of high-risk group for early-stage diffuse type gastric cancer in Japanese: Screening for diffuse gastric cancer. Journal of Gastroenterology and Hepatology 2012;27:598-602. [DOI: 10.1111/j.1440-1746.2011.06893.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
88 Lam KW, Lo SC. Discovery of diagnostic serum biomarkers of gastric cancer using proteomics. Proteomics Clin Appl. 2008;2:219-228. [PMID: 21136826 DOI: 10.1002/prca.200780015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
89 Leja M, Camargo MC, Polaka I, Isajevs S, Liepniece-Karele I, Janciauskas D, Rudzite D, Kikuste I, Vanags A, Kojalo I, Folkmanis V, Kirsners A, Tolmanis I, Rabkin CS. Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays. Helicobacter 2017;22. [PMID: 28557128 DOI: 10.1111/hel.12393] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
90 Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kuidelis G, Chiu H, Lin J. Value of gastrin-17 in detecting antral atrophy. Advances in Medical Sciences 2011;56:145-50. [DOI: 10.2478/v10039-011-0040-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
91 Frýdlová J, Kucerová Z, Tichá M. Interaction of pepsin with aromatic amino acids and their derivatives immobilized to Sepharose. J Chromatogr B Analyt Technol Biomed Life Sci 2008;863:135-40. [PMID: 18255363 DOI: 10.1016/j.jchromb.2008.01.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Graham DY, Kato M, Asaka M. Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing. Dig Liver Dis. 2008;40:497-503. [PMID: 18403275 DOI: 10.1016/j.dld.2008.02.032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
93 De Re V, Orzes E, Canzonieri V, Maiero S, Fornasarig M, Alessandrini L, Cervo S, Steffan A, Zanette G, Mazzon C, De Paoli P, Cannizzaro R. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer. Clin Transl Gastroenterol 2016;7:e183. [PMID: 27441820 DOI: 10.1038/ctg.2016.42] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
94 Zeng Z, Fu S, Hu P, Zhao L, Zhang H, Tang X, Yang X, Zeng Z. The diagnostic value of monoclonal gastric cancer 7 antigen: a systematic review with meta-analysis. Clin Exp Med. 2013;Epub ahead of print. [PMID: 23797567 DOI: 10.1007/s10238-013-0246-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
95 Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Long Q, Flanders WD, Bostick RM, Yuan Y. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: A longitudinal study. Int J Cancer. 2014; Jun 4. [Epub ahead of print]. [PMID: 24895149 DOI: 10.1002/ijc.29005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
96 Bornschein J, Selgrad M, Wex T, Kuester D, Malfertheiner P. Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol. 2012;12:10. [PMID: 22289789 DOI: 10.1186/1471-230x-12-10] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
97 Kim N. Screening and Diagnosis of Early Gastric Cancer. J Korean Med Assoc 2010;53:290. [DOI: 10.5124/jkma.2010.53.4.290] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
98 Ye DM, Xu G, Ma W, Li Y, Luo W, Xiao Y, Liu Y, Zhang Z. Significant function and research progress of biomarkers in gastric cancer. Oncol Lett 2020;19:17-29. [PMID: 31897111 DOI: 10.3892/ol.2019.11078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
99 Miftahussurur M, Waskito LA, Aftab H, Vilaichone RK, Subsomwong P, Nusi IA, Syam AF, Ratanachu-Ek T, Doohan D, Siregar G, Rezkitha YAA, Fauzia KA, Mahachai V, Yamaoka Y. Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations. PLoS One 2020;15:e0230064. [PMID: 32271765 DOI: 10.1371/journal.pone.0230064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Hirata K, Suzuki H, Matsuzaki J, Masaoka T, Saito Y, Nishizawa T, Iwasaki E, Fukuhara S, Okada S, Hibi T. Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy. J Clin Biochem Nutr. 2013;52:172-178. [PMID: 23524980 DOI: 10.3164/jcbn.12-107] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
101 Iino C, Shimoyama T, Chinda D, Arai T, Chiba D, Nakaji S, Fukuda S. Infection of Helicobacter pylori and Atrophic Gastritis Influence Lactobacillus in Gut Microbiota in a Japanese Population. Front Immunol. 2018;9:712. [PMID: 29681906 DOI: 10.3389/fimmu.2018.00712] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
102 Kaise M, Miwa J, Tashiro J, Ohmoto Y, Morimoto S, Kato M, Urashima M, Ikegami M, Tajiri H. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk. J Gastroenterol. 2011;46:736-745. [PMID: 21455714 DOI: 10.1007/s00535-011-0396-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
103 Malfertheiner P, Venerito M, Selgrad M. Helicobacter pylori infection: selected aspects in clinical management. Curr Opin Gastroenterol. 2013;29:669-675. [PMID: 24100726 DOI: 10.1097/mog.0b013e328365d443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
104 Zeng W, Zhang S, Yang L, Wei W, Gao J, Guo N, Wu F. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer. BMC Med Genet 2020;21:28. [PMID: 32041551 DOI: 10.1186/s12881-020-0967-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
105 Sun LP, Gong YH, Wang L, Yuan Y. Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. World J Gastroenterol. 2007;13:6562-6567. [PMID: 18161928 DOI: 10.3748/wjg.13.6562] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
106 Malfertheiner P, Selgrad M, Bornschein J. Helicobacter pylori: clinical management. Curr Opin Gastroenterol. 2012;28:608-614. [PMID: 23010682 DOI: 10.1097/mog.0b013e32835918a7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
107 Cooke CL, Torres J, Solnick JV. Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. 2013;4:532-540. [PMID: 23851317 DOI: 10.4161/gmic.25720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
108 Fan X, Qin X, Zhang Y, Li Z, Zhou T, Zhang J, You W, Li W, Pan K. Screening for gastric cancer in China: Advances, challenges and visions. Chin J Cancer Res 2021;33:168-80. [PMID: 34158737 DOI: 10.21147/j.issn.1000-9604.2021.02.05] [Reference Citation Analysis]
109 Coelho MCF, Ribeiro HG, Gomes CGO, Marinho FP, Barbosa AJA, Coelho LGV. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE. Arq Gastroenterol 2021;58:39-47. [PMID: 33909795 DOI: 10.1590/S0004-2803.202100000-08] [Reference Citation Analysis]
110 Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World J Gastroenterol 2019; 25(27): 3546-3562 [PMID: 31367156 DOI: 10.3748/wjg.v25.i27.3546] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
111 Lee JY, Kim N, Lee HS, Oh JC, Kwon YH, Choi YJ, Yoon KC, Hwang JJ, Lee HJ, Lee A, Jeong Y, Jo HJ, Yoon H, Shin CM, Park YS, Lee DH. Correlations among endoscopic, histologic and serologic diagnoses for the assessment of atrophic gastritis. J Cancer Prev 2014;19:47-55. [PMID: 25337572 DOI: 10.15430/jcp.2014.19.1.47] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
112 Kotachi T, Ito M, Yoshihara M, Boda T, Kiso M, Masuda K, Matsuo T, Tanaka S, Chayama K. Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and <b><i>Helicobacter pylori </i></b>Antibody: Relationship to Endoscopic Findings. Digestion 2017;95:314-8. [DOI: 10.1159/000477239] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
113 Uedo N, Yao K, Ishihara R. Screening and treating intermediate lesions to prevent gastric cancer. Gastroenterol Clin North Am. 2013;42:317-335. [PMID: 23639643 DOI: 10.1016/j.gtc.2013.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
114 Lee JY, Park KS, Lee HG, Baek WK, Cho KB, Lee YJ, Lee YS, Ryu SW. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer. Clin Exp Med 2017;17:403-10. [PMID: 27154568 DOI: 10.1007/s10238-016-0426-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
115 Nie Y, Wu K, Yu J, Liang Q, Cai X, Shang Y, Zhou J, Pan K, Sun L, Fang J, Yuan Y, You W, Fan D. A global burden of gastric cancer: the major impact of China. Expert Rev Gastroenterol Hepatol. 2017;11:651-661. [PMID: 28351219 DOI: 10.1080/17474124.2017.1312342] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
116 Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control 2010;21:163-70. [PMID: 19838812 DOI: 10.1007/s10552-009-9446-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
117 van der Poorten DK, McLeod D, Ahlenstiel G, Read S, Kwok A, Santhakumar C, Bassan M, Culican S, Campbell D, Wong SWJ, Evans L, Jideh B, Kane A, Katelaris CH, Keat K, Ko Y, Lee JA, Limaye S, Lin MW, Murad A, Rafferty M, Suan D, Swaminathan S, Riminton SD, Toong C, Berglund LJ. Gastric Cancer Screening in Common Variable Immunodeficiency. J Clin Immunol. 2018;38:768-777. [PMID: 30219982 DOI: 10.1007/s10875-018-0546-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
118 Mezmale L, Isajevs S, Bogdanova I, Polaka I, Krigere A, Rudzite D, Rudule A, Kikuste I, Parshutin S, Tazhedinov A, Mushinskiy D, Sametayev D, Belikhina T, Igissinov N, Park JY, Herrero R, Leja M. Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy. Asian Pac J Cancer Prev 2019;20:3825-9. [PMID: 31870128 DOI: 10.31557/APJCP.2019.20.12.3825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
119 Trivanovic D, Plestina S, Honovic L, Dobrila-Dintinjana R, Vlasic Tanaskovic J, Vrbanec D. Gastric cancer detection using the serum pepsinogen test method. Tumori 2021;:3008916211014961. [PMID: 33993805 DOI: 10.1177/03008916211014961] [Reference Citation Analysis]
120 Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa T. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009; 15(7): 853-859 [PMID: 19230047 DOI: 10.3748/wjg.15.853] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
121 Li QH, Yu M, Ding YL, Chen YX. ANKRD33 is overexpressed in gastric adenocarcinoma and predictive for poor prognosis. Biosci Biotechnol Biochem 2019;83:2075-81. [PMID: 31314707 DOI: 10.1080/09168451.2019.1642100] [Reference Citation Analysis]
122 Kitamura Y, Yoshihara M, Ito M, Boda T, Matsuo T, Kotachi T, Tanaka S, Chayama K. Diagnosis of Helicobacter pylori -induced gastritis by serum pepsinogen levels: Diagnosis of gastritis by serum markers. J Gastroenterol Hepatol 2015;30:1473-7. [DOI: 10.1111/jgh.12987] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
123 Leja M, Lapina S, Polaka I, Rudzite D, Vilkoite I, Daugule I, Belkovets A, Pimanov S, Makarenko J, Tolmanis I, Lejnieks A, Boka V, Rumba-Rozenfelde I, Vikmanis U. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 wk after completion of therapy. Medicina (Kaunas). 2014;50:8-13. [PMID: 25060199 DOI: 10.1016/j.medici.2014.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
124 Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol. 2013;23:492-501. [PMID: 23876852 DOI: 10.1016/j.semcancer.2013.07.004] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
125 Yashima K, Sasaki S, Koda M, Kawaguchi K, Harada K, Murawaki Y. Premalignant lesions in gastric cancer. Clin J Gastroenterol 2010;3:6-12. [PMID: 26189899 DOI: 10.1007/s12328-009-0130-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
126 Wang X, Ling L, Li S, Qin G, Cui W, Li X, Ni H. The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis. Medicine (Baltimore) 2016;95:e3599. [PMID: 27149493 DOI: 10.1097/MD.0000000000003599] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
127 Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol 2014; 20(38): 13842-13862 [PMID: 25320521 DOI: 10.3748/wjg.v20.i38.13842] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 145] [Article Influence: 19.1] [Reference Citation Analysis]
128 Chen XZ, Huang CZ, Hu WX, Liu Y, Yao XQ. Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening. Chin Med J (Engl). 2018;131:1232-1239. [PMID: 29722342 DOI: 10.4103/0366-6999.231512] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
129 Wang X, Lu B, Meng L, Fan Y, Zhang S, Li M. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Scand J Gastroenterol. 2017;52:822-827. [PMID: 28436254 DOI: 10.1080/00365521.2017.1315739] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
130 Ning P, Sun L, Dong N, Yuan Y. PGC-MG7 combination could be used as a follow-up panel for monitoring dynamical progression of gastric precancerous diseases. Chin J Cancer Res 2020;32:89-95. [PMID: 32194308 DOI: 10.21147/j.issn.1000-9604.2020.01.10] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Razuka-ebela D, Polaka I, Daugule I, Parshutin S, Santare D, Ebela I, Rudzite D, Vangravs R, Herrero R, Young Park J, Leja M. Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study. Diagnostics 2022;12:1166. [DOI: 10.3390/diagnostics12051166] [Reference Citation Analysis]
132 Shiotani A, Haruma K, Graham DY. Metachronous gastric cancer after successful Helicobacter pylori eradication. World J Gastroenterol. 2014;20:11552-11559. [PMID: 25206262 DOI: 10.3748/wjg.v20.i33.11522] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Zheng Z, Bu Z, Liu X, Zhang L, Li Z, Wu A, Wu X, Cheng X, Xing X, Du H, Wang X, Hu Y, Ji J. Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications. Chin J Cancer Res 2014;26:104-11. [PMID: 24653632 DOI: 10.3978/j.issn.1000-9604.2014.02.08] [Cited by in F6Publishing: 59] [Reference Citation Analysis]
134 Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, Jung HC, Song IS. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011;16:382-388. [PMID: 21923684 DOI: 10.1111/j.1523-5378.2011.00859.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 6.2] [Reference Citation Analysis]
135 El Abiad R, Gerke H. Gastric Cancer: Endoscopic Diagnosis and Staging. Surgical Oncology Clinics of North America 2012;21:1-19. [DOI: 10.1016/j.soc.2011.09.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
136 Kishino T, Oyama T, Tomori A, Takahashi A, Shinohara T. Usefulness and Limitations of a Serum Screening System to Predict the Risk of Gastric Cancer. Intern Med 2020;59:1473-80. [PMID: 32188803 DOI: 10.2169/internalmedicine.3521-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kiudelis G, Chiu H, Lin J. The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology. Dig Dis Sci 2009;54:2377-84. [DOI: 10.1007/s10620-009-0947-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
138 Kwak MS, Kim N, Lee HS, Lee HE, Jung HC, Song IS. Predictive power of serum pepsinogen tests for the development of gastric cancer in comparison to the histologic risk index. Dig Dis Sci 2010;55:2275-82. [PMID: 20306133 DOI: 10.1007/s10620-010-1181-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
139 Miike T, Yamamoto S, Miyata Y, Hirata T, Noda Y, Noda T, Suzuki S, Takeda S, Natsuda S, Sakaguchi M, Maemura K, Hashimoto K, Yamaji T, Abe H, Iwakiri H, Tahara Y, Hasuike S, Nagata K, Kitanaka A, Shimoda K. Surrounding Gastric Mucosa Findings Facilitate Diagnosis of Gastric Neoplasm as Gastric Adenoma or Early Gastric Cancer. Gastroenterol Res Pract 2016;2016:6527653. [PMID: 26858751 DOI: 10.1155/2016/6527653] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
140 Iida M, Ikeda F, Hata J, Hirakawa Y, Ohara T, Mukai N, Yoshida D, Yonemoto K, Esaki M, Kitazono T, Kiyohara Y, Ninomiya T. Development and validation of a risk assessment tool for gastric cancer in a general Japanese population. Gastric Cancer 2018;21:383-90. [PMID: 29043529 DOI: 10.1007/s10120-017-0768-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
141 Takeoka A, Tayama J, Yamasaki H, Kobayashi M, Ogawa S, Saigo T, Hayashida M, Shirabe S. Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome. PLoS One 2016;11:e0166588. [PMID: 27851820 DOI: 10.1371/journal.pone.0166588] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
142 Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2-9. [PMID: 22188910 DOI: 10.1111/j.1751-2980.2011.00550.x.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Han XL, Yi CL, Ma JD, He Y, Wu LM, Wang YF, Yang HJ, Liang DY, Shi JF. Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer. Lab Med 2021:lmab035. [PMID: 34508270 DOI: 10.1093/labmed/lmab035] [Reference Citation Analysis]
144 Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6-30. [PMID: 27707777 DOI: 10.1136/gutjnl-2016-312288] [Cited by in Crossref: 1166] [Cited by in F6Publishing: 992] [Article Influence: 194.3] [Reference Citation Analysis]
145 Kato S, Matsukura N, Matsuda N, Tsuchiya S, Naito Z, Tajiri T. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach. J Gastroenterol Hepatol. 2008;23 Suppl 2:S258-S261. [PMID: 19120908 DOI: 10.1111/j.1440-1746.2008.05447.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
146 Senmaru T, Fukui M, Tanaka M, Kuroda M, Yamazaki M, Oda Y, Naito Y, Hasegawa G, Toda H, Yoshikawa T. Atrophic gastritis is associated with coronary artery disease. J Clin Biochem Nutr. 2012;51:39-41. [PMID: 22798711 DOI: 10.3164/jcbn.11-106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
147 Tokunaga M, Hiki N, Ohyama S, Nunobe S, Miki A, Fukunaga T, Seto Y, Sano T, Yamaguchi T. Effects of reconstruction methods on a patient’s quality of life after a proximal gastrectomy: subjective symptoms evaluation using questionnaire survey. Langenbecks Arch Surg. 2009;394:637-641. [PMID: 19066939 DOI: 10.1007/s00423-008-0442-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
148 Lee SY. Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection. Korean J Intern Med. 2016;31:835-844. [PMID: 27604795 DOI: 10.3904/kjim.2016.166] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
149 He C, Tu H, Sun L, Xu Q, Li P, Gong Y, Dong N, Yuan Y. Helicobacter pylori-related host gene polymorphisms associated with susceptibility of gastric carcinogenesis: a two-stage case-control study in Chinese. Carcinogenesis 2013;34:1450-7. [DOI: 10.1093/carcin/bgt079] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
150 Penno MA, Klingler-Hoffmann M, Brazzatti JA, Boussioutas A, Putoczki T, Ernst M, Hoffmann P. 2D-DIGE analysis of sera from transgenic mouse models reveals novel candidate protein biomarkers for human gastric cancer. J Proteomics 2012;77:40-58. [PMID: 22789672 DOI: 10.1016/j.jprot.2012.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
151 Juan Cai W, Yin L, Kang Q, Chen Zeng Z, Liang Wang S, Cheng J. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer. Sci Rep 2017;7:43536. [PMID: 28251999 DOI: 10.1038/srep43536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
152 Zhang X, Xue L, Xing L, Wang J, Cui J, Mi J, Xing X, Wang J, Du Z, Misumi J. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community. Int J Cancer. 2012;130:1614-1619. [PMID: 21547904 DOI: 10.1002/ijc.26172] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
153 Ozcan S, Barkauskas DA, Renee Ruhaak L, Torres J, Cooke CL, An HJ, Hua S, Williams CC, Dimapasoc LM, Han Kim J. Serum glycan signatures of gastric cancer. Cancer Prev Res (Phila). 2014;7:226-235. [PMID: 24327722 DOI: 10.1158/1940-6207.capr-13-0235] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
154 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Critical Reviews in Oncology/Hematology 2009;71:127-64. [DOI: 10.1016/j.critrevonc.2009.01.004] [Cited by in Crossref: 266] [Cited by in F6Publishing: 262] [Article Influence: 20.5] [Reference Citation Analysis]
155 Gong EJ, Lee JY, Bae SE, Park YS, Choi KD, Song HJ, Lee GH, Jung HY, Jeong WJ, Cheon GJ, Yook JH, Kim BS. Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology.PLoS One. 2018;13:e0195264. [PMID: 29621300 DOI: 10.1371/journal.pone.0195264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
156 Oda I, Gotoda T. Remarkable progress in endoscopic resection of early gastric cancer. Journal of Gastroenterology and Hepatology 2009;24:1313-4. [DOI: 10.1111/j.1440-1746.2009.05975.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
157 Deng K, Zhou LY, Lin SR, Li Y, Chen M, Geng QM, Li YW. A novel approach for the detection of early gastric cancer: fluorescence spectroscopy of gastric juice. J Dig Dis. 2013;14:299-304. [PMID: 23356830 DOI: 10.1111/1751-2980.12040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
158 Gruno M, Peet N, Tein A, Salupere R, Sirotkina M, Valle J, Peetsalu A, Seppet EK. Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells. J Gastroenterol. 2008;43:780-788. [PMID: 18958547 DOI: 10.1007/s00535-008-2231-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
159 Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method". Proc Jpn Acad Ser B Phys Biol Sci 2011;87:405-14. [PMID: 21785258 DOI: 10.2183/pjab.87.405] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 12.3] [Reference Citation Analysis]
160 Takata S, Ito M, Wada Y, Yoshihara M, Tanaka S, Chayama K. Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients. J Gastroenterol 2009;44:405-11. [DOI: 10.1007/s00535-009-0015-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
161 Ghidini M, Petrillo A, Botticelli A, Trapani D, Parisi A, La Salvia A, Sajjadi E, Piciotti R, Fusco N, Khakoo S. How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. J Clin Med 2021;10:1412. [PMID: 33915839 DOI: 10.3390/jcm10071412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Anderson BW, Suh YS, Choi B, Lee HJ, Yab TC, Taylor WR, Dukek BA, Berger CK, Cao X, Foote PH, Devens ME, Boardman LA, Kisiel JB, Mahoney DW, Slettedahl SW, Allawi HT, Lidgard GP, Smyrk TC, Yang HK, Ahlquist DA. Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma. Clin Cancer Res 2018;24:5724-34. [PMID: 29844130 DOI: 10.1158/1078-0432.CCR-17-3364] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
163 Park JY, von Karsa L, Herrero R. Prevention strategies for gastric cancer: a global perspective. Clin Endosc. 2014;47:478-489. [PMID: 25505712 DOI: 10.5946/ce.2014.47.6.478] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
164 Shiota S, Mahachai V, Vilaichone RK, Ratanachu-ek T, Tshering L, Uchida T, Matsunari O, Yamaoka Y. Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer. J Med Microbiol. 2013;62:1571-1578. [PMID: 23831768 DOI: 10.1099/jmm.0.060905-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
165 di Mario F, Cavallaro LG. Non-invasive tests in gastric diseases. Dig Liver Dis. 2008;40:523-530. [PMID: 18439884 DOI: 10.1016/j.dld.2008.02.028] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
166 Uedo N, Yoshio T, Yoshinaga S, Takeuchi M, Hatta W, Yano T, Tanuma T, Goto O, Takahashi A, Tong D, Lee YY, Nakayama Y, Ichihara S, Gotoda T. Endoscopic gastric mucosal atrophy distinguishes the characteristics of superficial esophagogastric junction adenocarcinoma. Digestive Endoscopy 2017;29:26-36. [DOI: 10.1111/den.12849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
167 Miftahussurur M, Nusi IA, Akil F, Syam AF, Wibawa IDN, Rezkitha YAA, Maimunah U, Subsomwong P, Parewangi ML, Mariadi IK, Adi P, Uchida T, Purbayu H, Sugihartono T, Waskito LA, Hidayati HB, Lusida MI, Yamaoka Y. Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia. PLoS One 2017;12:e0176203. [PMID: 28463979 DOI: 10.1371/journal.pone.0176203] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
168 Takeoka A, Tayama J, Kobayashi M, Sagara I, Ogawa S, Saigo T, Hayashida M, Yamasaki H, Fukudo S, Shirabe S. Psychological effects of Helicobacter pylori -associated atrophic gastritis in patients under 50 years: A cross-sectional study. Helicobacter 2017;22:e12445. [DOI: 10.1111/hel.12445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]